Two new Ebola drugs report a 90% survival rate
BBC - 13-Aug-2019Thanks to this cocktail of 3 antibodies, Ebola no longer means impending death
Join the club for FREE to access the whole archive and other member benefits.
Research to understand, treat, and prevent infectious, immunologic, and allergic diseases.
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. Posted comments and images do not necessarily represent the views of NIAID, NIH.
Visit website: https://www.niaid.nih.gov/
national-institute-of-allergy-and-infectious-diseases-niaid
See also: National Institutes of Health (NIH) - Medical research agency that supports scientific studies
Details last updated 23-Nov-2019
Director of the National Institute of Allergy and Infectious Diseases and Chief Medical Advisor to the President of United States
Thanks to this cocktail of 3 antibodies, Ebola no longer means impending death
The 1918 influenza pandemic: the most devastating infectious disease in history took 50 million t...